Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
A specific vaccine to protect patients with multiple sclerosis from herpes zoster.
Further evidence for the neuroprotective role of oleanolic acid in a model of focal brain hypoxia in rats.
Noise in multiple sclerosis: unwanted and necessary.
Reproducibility of T2 * mapping in the human cerebral cortex in vivo at 7 tesla MRI.
Induction of oxiapoptophagy on 158N murine oligodendrocytes treated by 7-ketocholesterol-, 7β-hydroxycholesterol-, or 24(S)-hydroxycholesterol: Protective effects of α-tocopherol and docosahexaenoic acid (DHA; C22:6 n-3).
The evolution of vertebrate and invertebrate myelin: a theoretical computational study.
Effect of a neurohospitalist service on outcomes at an academic medical center.
A prospective study of "undiagnosed" isolated myelopathy: I. Case selection and clinical features.
Disease Activity Free Status: A New End Point for a New Era in Multiple Sclerosis Clinical Research?
Tregitope Peptides: The Active Pharmaceutical Ingredient of IVIG?
Cognitive Reserve as a Useful Concept for Early Intervention Research in Multiple Sclerosis.
A cohort study of Han Chinese MFN2-related Charcot-Marie-Tooth 2A.
Being Kind to Your Future Self: Probability Discounting of Health Decision-Making.
Biomechanical analysis of spasticity treatment in patients with multiple sclerosis.
Personality characteristics in MS patients: The role of avoidant personality.
Effective communication at the point of multiple sclerosis diagnosis.
Nurses' perspective on approaches to limit flu-like symptoms during interferon therapy for multiple sclerosis.
Erratum to: Altered serotonin transporter availability in patients with multiple sclerosis.
B-cell depletion in children with neuroimmunologic conditions: The learning curve.
Optic neuritis: Experience from a south Indian demyelinating disease registry.
What place for {blacktriangledown}cannabis extract in MS?
Mental comorbidity and multiple sclerosis: validating administrative data to support population-based surveillance.
Serum and cerebrospinal fluid heavy neurofilaments and antibodies against them in early multiple sclerosis.
Segmentation of magnetization transfer ratio lesions for longitudinal analysis of demyelination and remyelination in multiple sclerosis.
Symptoms Related to Tumor Necrosis Factor Receptor 1-associated Periodic Syndrome, Multiple Sclerosis, and Severe Rheumatoid Arthritis in Patients Carrying the TNF Receptor Superfamily 1A D12E/p.Asp41Glu Mutation.
Pages
« first
‹ previous
…
479
480
481
482
483
484
485
486
487
…
next ›
last »